Security key
825693203
- Security type / class
- Equity / COM
- Total 13F shares
- 86,842
- Total 13F value
- $34,598
- Share change
- +20,981
- SEC-reported price per share
- $0.40
- Number of holders
- 6
- Value change
- +$7,966
- Number of buys
- 4
- Number of sells
- 4
Report period
Q2 2024
Institutions
6
Top holders
6
SHPH full security history
Ownership snapshot
Full 13F holder table
Shuttle Pharmaceuticals Holdings, Inc. SEC filings
Shuttle Pharmaceuticals Holdings, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SHPH - SHUTTLE PHARMACTCLS HLDGS IN - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Anatoly Dritschilo
Disclosed value leader
Mira Jung
Comparable rows
0/15
Latest evidence
01 May 2024
3/4/5
13F
Highest disclosed value: $1,530,865
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Mira Jung has the largest disclosed position value at $1.53M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Mira Jung's linked filing trail.
Disclosed position value
Top 5
Anatoly Dritschilo
$1.48M
Mira Jung
$1.53M
William H. Adkins
$85.3K
Bette Jacobs
$62.6K
Michael Vander Hoek
$48.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Anatoly Dritschilo |
3/4/5
CEO and Chairman, Director, 10%+ Owner
|
—
denominator unverified
|
$1,484,281
3,204,407 shares
|
— | 14 Aug 2023 |
| Mira Jung |
3/4/5
Chief Scientific Officer
|
—
denominator unverified
|
$1,530,865
135,715 shares
|
— | 01 May 2024 |
| William H. Adkins |
3/4/5
Former Director
|
—
mixed-class rows
|
$85,262
322,960 shares
mixed-class rows
|
— | 29 Dec 2022 |
| Bette Jacobs |
3/4/5
Director
|
—
mixed-class rows
|
$62,646
58,285 shares
mixed-class rows
|
— | 13 Dec 2023 |
| Michael Vander Hoek |
3/4/5
Chief Financial Officer
|
—
denominator unverified
|
$48,104
103,852 shares
|
— | 08 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$15,004
36,957 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
86,842
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
7
Q2 2024 holders
6
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|